Factor Therapeutics director retires

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
Webinar ReplaysNew Corporate Realities: Blending Geopolitics, Data, and Digital Transformation
- 07/21/2022
- On-Demand
- 1 Hour
In PersonInteract 2022
- 09/15/2022
- 225 Liberty Street, New York, New York
- 225 Liberty Street
In Person451Nexus
- 10/03/2022
- ARIA Resort and Casino, Las Vegas, Nevada
Platforms
Other Products
- Leveraged Commentary and Data
- Research Online

In This List

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations

12 Dec, 2018

Author Hassan Aftab
Theme Healthcare & Pharmaceuticals

Factor Therapeutics Ltd. said Robert Ryan retired from the board.

Ryan joined the board as a nonexecutive director in September 2016. He is president and CEO of Innova Therapeutics.

Darra, Australia-based Factor Therapeutics is a clinical-stage biotechnology company that develops and commercializes treatments for wound care and healing.